1 asset in Solid Pseudopapillary Neoplasm Of The Pancreas

Therapeutic assets addressing Solid Pseudopapillary Neoplasm Of The Pancreas, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tegavivint Solid Pseudopapillary Neoplasm Of The Pancreas	Children's Oncology Group	P1/2	CCC (48)